Tag Archives: BLFE
BioLife Sciences Inc. (OTC: BLFE) Announces Letter of Intent for Exclusive Licensing Deal with Canadian Firm
HENDERSON, NV, Feb. 02, 2023 (GLOBE NEWSWIRE) — via NewMediaWire — BioLife Sciences (OTCPK: BLFE) is pleased to announce that it has entered into a non-binding letter of intent (“LOI”) dated February 01, 2023 with Canadian Company–Work In Motion pursuant … Continue reading
Posted in Client Announcements, Press Release
Tagged BioLife Sciences, BLFE, OTC Markets, Press Releases
Comments Off on BioLife Sciences Inc. (OTC: BLFE) Announces Letter of Intent for Exclusive Licensing Deal with Canadian Firm
Cervitude IR Retained by BioLife Sciences OTCM: BLFE
BioLife Sciences Inc. (OTCM: BLFE) today retained Cervitude Intelligent Relations to assist with investor relations, market awareness and investor outreach services. BioLife Sciences is a commercialization accelerator, licensor, and developer of innovative and disruptive technologies for the healthcare, beauty, food, … Continue reading
Posted in Dealmakers
Tagged BioLife Sciences, BLFE, Investor Relations
Comments Off on Cervitude IR Retained by BioLife Sciences OTCM: BLFE